Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more
Episode Description
May 09, 2017 edition of the weekly JAMA Editors' Summary
We use cookies to run this site. Analytics cookies, which show us how it's used, stay off unless you accept them. Change your mind any time with the cookie button at the bottom right. How we use cookies